What are we reading?

  1. As Coronavirus infection slows, South Korea prepared for life after social distancing (here)
  2. Bill Ackman clarifies on his CNBC comments (here)
  3. Where does the $2T in the U.S. stimulus bill go (here) from reddit
  4. Covid impact on restaurants in the U.S. (here) and (here)
  5. State by state shutdown won’t work – Bill Gates (here)
  6. Investing in healthcare: threat and opportunity of the decade ahead (here)
  7. Trump orders GM to make ventilators under the Defense Production Act (here)
  8. Miss the worst days, miss the best days (here)
  9. Corona, Cheesecake & testing the mirage of lease-debt equivalence (here)
  10. I became a disciplined investor over 40 years. The virus broke me in 40 days (here)

Managing downside risk in a downturn!

As value investors, a lot of us are starting to find the environment to be idea rich after a long time. Finally, the valuations are compelling, the companies we have researched are cheap, the war chest is ready to crack open, ready to be used. During such times, there are new risks that needs to be actively managed. While I watched the 2009 recession hunting for a job in the U.S, I did not live through the panic in the securities market during the recession of 2008/9. This is my first real test. There have been drawdowns in the past which have been sharp and never so deep.

One of the risks is through concentrated positions. A ton of wealth has been made through concentrated positions. 2-3 years from now, when the markets are back up (hopefully) there will be stories about investors who bought by the truckloads during the downturn and made a killing on some of the ideas. What won’t get said, are the ton of the people who got crushed during the downturn by investing in concentrated positions (2/3/4 positions) and the companies going to zero. Survivorship bias will exist in this regard. People recall Mike Burry a lot more than Bill Miller. It is highly preferable to give up some upside in order to reduce the chances of going back to Go on the board.

Here is where capital allocation and portfolio management go hand in hand. As much as tempting it is to back the truck into a certain securities and concentrate, a dose of diversification will prevent complete blow ups from happening. There are multiple ways this can be achieved. Buying a basket of stocks in a similar category, allocating a certain % to index funds, looking at preferred stocks, closed end funds, special situations etc. can provide other opportunities even in the securities space. Of course, this conversation here is limited to the securities space where we are finding bargains at this point. Other asset classes are not considered here.

Some of the steps that I am taking while managing through this downturn :

  1. Kept aside cash required to manage next 2-3 years + emergency cash even I were to lose my job.
  2. Had a clear plan written down on how portfolio management would happen in a 30-40% down market when I was clear and lucid.
  3. Diversifying more than usual while adding new bargains
  4. Baskets of stock in a similar story. Everything might not go to zero (unless my stock picking skills are similar to the CDO’s constructed by US banks a decade ago)
  5. Index funds / quasi index like Berkshire get a certain allocated % of the capital allotted
  6. The rules make is tougher and tougher to double down into the same ideas

I am very interested to see how this will pan out. While the ride has been painful, I am far from panicking yet. Just a pit in the stomach once in a while so far.

GCI Liberty: Thoughts!

I have been looking at various securities this weekend to work on what is finally turning out to be an idea-rich environment. GCI Liberty, the sole cable provider in Alaska, was an interesting company to look at given that it belongs to the Malone complex. Amongst the dozens of securities and tracking stocks that the Liberty empire has, GLIBP (GCI Liberty Preferred) and GLIBA (GCI Liberty Common A) are two such securities.

GCI Liberty has always traded at a discount to the underlying Liberty broadband and Charter shares. I wanted to do a quick back of the envelope NAV calculation to see the level of discount and whether it would interest me among all the other opportunities on hand. Unfortunately, the discount using a fairly conservative approach turned out to be close to 20% and not much higher that I was expecting. Please note that the below NAV calculation aims to capture only the key components and is a rough guesstimate of the NAV.

Screenshot 2020-03-23 at 5.12.43 PM

However, the cumulative, non-convertible preferred stock trading at $22.25 with a 7% coupon (payable in 4 quarterly payments) with a $25 liquidation value callable after 2021 with a yield of 8.71% is mildly more interesting play with the common equity providing the cushion required for the dividend payments.

Update: To reflect the cash on the balance sheet. Thanks to Rocco for pointing it out.

Piramal: Thoughts on current state.

Piramal closed on March 20th at a market price of INR 684 with a market cap of INR 15.4K crores. The shares outstanding as of Dec 31st was 20.45 crores with a dividend yield of 4%. Given the fall from grace the stock price has experienced, it will be worthwhile to examine both the liability side and the asset side and summarise what we know.


  1. Company capitalisation and access to capital: A classic example of this was Yes Bank where they struggled to raise capital and the bad loans soured and the RBI stepped in. However, that is not the case with Piramal. With the recent cap raise and the sale of DRG, the net worth is estimated to be close to 34K crores or INR 1382 / share.
  2. DRG: Clarivate has confirmed that is has closed the DRG for $950M with a payment of $900M to Piramal Enterprises which amounts to close to INR 6K crores. You can see the link of Clarivate’s SEC filing here on March 2nd. We can safely assume that this INR 6K crores is available to Piramal for now. This is approximately 39% of the market cap of the company as of March 21st.
  3. The rights issue for INR 5,400 crores that the company executed in Jan was fully subscribed and the company has received the proceeds. It is important to note that the promoters of the company fully participated in the rights issue. This is another 35% of the market cap of the company.
  4. Less than 9 months ago, the company sold its stake in STFC for 2,300 crores.
  5. It is clear that the company has had access to liquidity from the stake sales very close to the market cap of the company today.
  6. In addition, the company has announced the monetisation of the Shriram stake, which is estimated to bring 7-8K crores into the coffers. However, it needs to be seen whether with the economy further deteriorating drastically and the Covid impact whether the Sep timeframe given by the management holds good.
  7. Furthermore, the company has announced that they are considering a stake sale of 20% in the Pharma business and the proceeds here will fund the further growth of Pharma and will ensure that any incremental capital is available for the financial services business.


  1. The company needs to have the ability to roll over the debt or repay the debt over the next few months to a year while the economy suffers from both a prolonged real estate crisis and the impact of Covid.
  2. The company has moved from reliance on commercial paper and reduced the exposure from 18K crores 18 months ago to negligible amount as of Dec 2019.
  3. It has gone into longer term bank debt and bank funding has increased from 49% to 67% of the total borrowings. (See appendix A for points 2. and 3.)
  4. Recently, the company has accessed 1,900 crores at 9% per annum which provides further comfort that the cost of funding is coming down.
  5. What is even more important in my opinion is that the banks have had access to the books and have examined closely the assets of the book before lending to Piramal. This was confirmed by the management during one of the recent conference calls on March 12th. (Appendix B)
  6. The other thing that NBFC’s have to worry about is the ALM mis-match. Appendix 3 shows that close to 17K crores outflow is expected up to the next 12 months. Given the fact that they have close to 4.5K crores cash, Pharma generating proforma 1.5K crore operating cash flow over 12 months, capital raise and access to cash, high CAR of 32% before considering any payments coming from projects being refinanced or closed or the book run down, there should be a fair amount of comfort that the company will be fine in the next 12 months.

Asset Quality: The wholesale financing book is what seems to have scared the investors the most.

  1. The total finance loan book is INR ~51K crores. Housing finance is 6K crores, commercial real estate is 11K crores, CPG and ECL is 9K crores and the big chunk which is the residential real estate is 25K crores.
  2. So far, the company has reported only 1.8% GNPA and 1000 crores of provisioning so far. Again, given the recent experience with Yes Bank, the investors are being wary of companies that have exposure to stressed sectors but reporting very little GNPA and defaults.
  3. Firstly, it must be noted that, Piramal did not have any exposure to Yes Bank, Altico, IL&FS, DHFL, ADAG etc. which have gone bust. The fact that the company has dodged exposure to these stressed accounts indicate a certain level of quality of the book. Unlike Yes Bank, which had exposure to every stressed asset, Piramal seems to have dodged the bullet so far.
  4. In the housing finance segment, there is speculation that the government might provide some relief to MSME and non-salaried people towards EMI’s to help through the Covid situation. Hopefully, they will provide extended DPD guidelines to NBFC’s as well. Even if not, the GNPA’s might spike up. Unless Covid paralyses the economy over the next 6-12 months and things don’t get back to normal, the risk in the actual underlying defaults will be negligible. It must also be noted that the company has stressed multiple times that it is providing adequate LTV and security provisions in its loan book.
  5. The commercial real estate has not seen much stress in the last 2-3 years. Unless something new comes up as part of Covid and extended significant delays in construction, it would be fair to say that the commercial book will be fine.
  6. The corporate lending groups with its 9K crore book will see stress. We know that the Delhi Baroda truck financing with exposure of INR 75 crores is stressed. The Essel exposure from Piramal is close to INR 200 crores now. We should clearly expect to see more slippages from this and the GNPA shoot up over the next few months.
  7. The real estate wholesale financing segment is 25K crores. Piramal has run down close to 10K crores of the this segment over the last 18 months. The number of developers who were more than 15% of the net worth of the company has come down to 4 to 1. The one is Lodha.
  8. Lodha will have a INR 2500 crore exposure to Piramal by April.  A couple of positive developments. In the recent call, it was clarified that the capital under security for this loan is close to INR 6000 crores (Appendix D) Finished goods inventory is close to INR 2300 crores with another INR 1000 crores completing over the next 3 months. In addition, Lodha just tapped the capital markets to refinance and repay bonds. See link here. In addition, the last 12 months sales for Lodha was close to 7000 crores and continues to the largest real estate developer in India. While the current Covid shutdown and the resulting economic bumps might stagger payments, it is highly unlikely that Piramal will need to take a write down on  Lodha.
  9. In addition, it is worth noting that some of the accounts that Piramal has in stage 3 assets, they are moving to get the title of the lands and recover the loan. Easier said than done but the company has demonstrated that they can execute such moves well in the past.
  10. So far, the company has demonstrated that is can manage the risk and the recoveries from customers that it is lending to, have a low LTV ratio and a better than average risk monitoring system.
  11. It must be noted that no way does this mean that the loan book won’t sour in the near future or the stage 2/3 provisions will need to go up and more money needs to be set aside for provisioning, all we get comfort from is that the fact the management seems to have demonstrated reasonably well that it can manage the risk it is taking on.

Management: Understated in the market is what I call the Say-Do ratio of the management. Lots of companies make promises but it is execution that matters. Contrast the equity raising by both Yes Bank and Piramal around the same timeframe and the results each of them has had.

  1. Raising of capital through rights sale
  2. Completing the promise of bring in 8-10K crore equity into the business
  3. Reducing reliance on commercial paper. The management laid out the roadmap 12 months ago.
  4. Reducing reliance on exposure to single borrower names
  5. Piramal has put balance sheet strength over sheer growth reversing the earlier stance.
  6. The only con that I can direct to the management is the fact that they did not build a Fort Knox balance sheet from the start and had to go through several stake sales, cap raises (albeit at a premium to today’s stock price) to build a solid balance sheet. However, the management has shown that it will learn and correct mistakes quickly.

Unless it comes to light that the management is completely fraudulent, it is reasonable to assume that Piramal will weather the storm.


  1. The December end shares outstanding was: 20.5 crores. With INR 5,400 crores coming in at INR 1,300; approx. 4.2 more shares would be added. The total new shareholding will be at 24.6-24.7 crore shares.
  2. Total net worth at INR 34K crores or 1,382 per share and CMP is at 684 or 0.5 P/B.
  3. Total borrowings are at 50K crores.
  4. Enterprise value is at 64K crores: 50K borrowings + 14K  market cap.
  5. SOTP would be as follows (following Dec 2019):
    1. Shriram stake – INR 6-8K Crores
    2. DRG Cash – INR 6K Crores
    3. Rights issue – INR 5.4K Crores
    4. Commercial RE – INR 11 K Crores
    5. Housing Finance – INR 6K crores
    6. Pharma business – INR 15K Crores (@ 10X EV/EBITDA)
    7. Cash – INR 4.5K Crores.
  6. Sub-total of assets before residential RE and CPG/ECL assets is approx. INR 56K crores.
  7. The market is today valuing the INR 34K crores worth of assets at less than INR 10K Crores. It can also be reasonably shown that the INR 2.5K Crores to Lodha is reasonably safe. So, the market is valuing close to INR 31K crores of others at INR 7.5K crores.
  8. Depending on the risk appetite of the investor, it will open up interesting possibilities.

I am interested in your thoughts and comments. please mail me: contact@beowulfcap.com

Disclosure: Long several NBFC’s and Banks including Piramal.

Disclaimers: See FAQ here. Not a recommendation. Not a registered advisor. Just sharing my thoughts.

Appendix A:

Screenshot 2020-03-22 at 9.53.53 AM

Appendix B:

Screenshot 2020-03-22 at 9.57.00 AM

Appendix C:

Screenshot 2020-03-22 at 10.48.27 AM

Appendix D:

Screenshot 2020-03-22 at 10.22.57 AM

Markel Corp. equity portfolio

Reposting with edits as the prior post is not updating online.

Markel (MKL) closed at $785/share as of March 20th. Since the reported book value of MKL was $802 as of Dec 31st, I wanted to look into the equity portfolio of $MKL and see the effect on its book value. At the closing price of $1,143 on Dec 31st, MKL traded at a P/B of 1.42.

Given the carnage in the market, the equity value of its U.S listed stocks are down from $7.2B to $4.95B (see below) which is 31% below 12/2019. Of course, there is a possibility that Markel could have sold stocks before the meltdown or could have increased the equity holdings materially but neither will be known at least until early May.

With 13.7M shares outstanding as of 31/12, the book value change just from marking the equity book to market would be $162/share. Adjusting for this, the book value for Markel would be ~$640/share. Markel also has deferred taxes of $996M related to investments. This translates to $72/share. At the corporate tax rate of 21.2% (2019 rate) Markel can offset about $34/share of the equity price decline resulting in a book value of $674/share. The new price/book will be 1.16. This is definitely more cheaper than 31/12.

At this point, it is also not clear whether the insurance operation will take any hit due to any exposure to Covid as well. While Markel does trade much cheaper than it has for a long time, it is far from trading below book value like it did very briefly when the acquisition of Alterra was announced.

Disclosure: Long Markel.

Thanks for @rationalwalk for pointing out the deferred taxes.

Stock Value as of 31/12 Price on March 20th Portfolio Value
KMX – CarMax Inc. $430,729,000 $44.27 $217,501,608.90
BRK.A – Berkshire Hathaway CL A $375,247,000 $257,346.00 $284,367,330.00
BRK.B – Berkshire Hathaway CL B $345,720,000 $170.06 $259,572,271.42
BAM – Brookfield Asset Management Inc. $334,930,000 $38.65 $223,962,874.65
DIS – Walt Disney Co. $268,206,000 $85.98 $159,443,891.40
MAR – Marriott Int’l. $240,057,000 $74.58 $118,229,362.02
DEO – Diageo plc $227,333,000 $109.56 $147,884,088.00
HD – Home Depot $200,909,000 $152.15 $139,978,000.00
GOOG – Alphabet Inc. CL C $181,244,000 $1,072.32 $145,361,554.56
AMZN – Amazon Corp. $180,963,000 $1,846.09 $180,791,285.88
V – Visa Inc. $179,472,000 $146.83 $140,244,674.50
UNH – United Health Group Inc. $176,094,000 $206.59 $123,747,410.00
DE – Deere & Co. $174,282,000 $111.63 $112,288,617.00
WBA – Walgreens Boots Alliance $121,310,000 $46.42 $95,509,150.00
BLK – BlackRock Inc. $110,594,000 $354.72 $78,038,400.00
RLI – RLI Corp. $107,779,000 $73.63 $88,155,137.36
ADI – Analog Devices $101,705,000 $85.08 $72,812,399.88
TXN – Texas Instruments $91,663,000 $97.60 $69,735,200.00
ADP – Automatic Data Processing Inc. $90,484,000 $112.06 $59,470,242.00
JNJ – Johnson & Johnson $89,097,000 $119.89 $73,228,812.00
AAPL – Apple Inc. $88,105,000 $229.24 $68,780,023.40
UL – Unilever PLC $87,333,000 $47.17 $72,056,892.00
GS – Goldman Sachs Group $78,613,000 $138.41 $47,322,379.00
MSFT – Microsoft Corp. $74,847,000 $137.35 $65,189,057.00
LOW – Lowe’s Cos. $69,580,000 $66.36 $38,555,160.00
WSO – Watsco Inc. $69,808,000 $145.71 $56,462,625.00
BX – The Blackstone Group $68,415,000 $37.67 $46,070,410.00
GD – General Dynamics $68,247,000 $113.99 $44,114,130.00
ADM – Archer-Daniels-Midland $67,824,000 $30.61 $44,791,613.00
ANTM – Anthem Inc. $67,655,000 $191.59 $42,916,160.00
MMC – Marsh & McLennan $67,905,000 $79.87 $48,680,765.00
NVO – Novo Nordisk A S $62,221,000 $49.46 $53,169,500.00
MA – Mastercard Inc. $61,465,000 $211.42 $43,520,807.00
AXP – American Express $59,911,000 $74.12 $35,670,250.00
ECL – Ecolab Inc. $59,113,000 $141.88 $43,457,844.00
ITW – Illinois Tool Works $57,302,000 $125.78 $40,123,820.00
BF.A – BROWN FORMAN Inc. A $52,916,000 $45.94 $38,727,420.00
SCHW – Charles Schwab $51,493,000 $30.75 $33,293,025.00
MCO – Moody’s Corp. $49,804,000 $175.80 $36,879,324.00
APO – Apollo Global Management $48,306,000 $26.84 $27,175,500.00
PGR – Progressive Corp. $46,329,000 $68.28 $43,699,200.00
SBUX – Starbucks Corp. $45,689,000 $58.03 $30,156,334.04
NSC – Norfolk Southern Corp. $44,552,000 $123.71 $28,391,445.00
SMG – Scotts Miracle-Gro Co. $44,808,000 $83.53 $35,249,660.00
TRV – Travelers Companies Inc. $43,139,000 $89.51 $28,195,650.00
CAT – Caterpillar Inc. $41,941,000 $95.50 $27,122,000.00
CFX – Colfax Corp. $41,294,000 $16.40 $18,615,148.00
MMM – 3M Co. $40,312,000 $124.89 $28,537,365.00
SPGI – S&P Global Inc. $40,138,000 $208.79 $30,692,130.00
KKR – KKR & Co. L.P. $39,838,000 $19.07 $26,043,899.00
CG – Carlyle Group $38,817,000 $19.39 $23,461,900.00
WHR – Whirlpool Corp. $38,733,000 $74.45 $19,546,028.55
HAS – Hasbro Inc. $38,442,000 $46.10 $16,780,400.00
TROW – T. Rowe Price Group $38,258,000 $90.34 $28,366,760.00
NKE – NIKE Inc. $37,079,000 $67.45 $24,686,700.00
SRCL – Stericycle Inc. $36,244,000 $44.68 $25,378,240.00
MHK – Mohawk Industries $35,595,000 $58.66 $15,310,260.00
MSCI – MSCI Inc. $35,370,000 $243.07 $33,300,590.00
LYV – Live Nation Inc. $34,927,000 $33.97 $16,601,139.00
ACN – Accenture $33,565,000 $149.94 $23,900,436.00
ITIC – Investors Title Co. $33,957,000 $110.90 $23,654,970.00
UTX – United Technologies $33,546,000 $82.53 $18,486,720.00
BF.B – Brown-Forman Corp. $32,055,000 $48.85 $23,164,034.95
TSN – Tyson Foods $32,365,000 $53.62 $19,061,910.00
NVR – NVR Inc. $31,819,000 $2,326.89 $19,441,165.95
BA – Boeing Co. $30,752,000 $95.01 $8,968,944.00
FDS – FactSet Research Systems $31,273,000 $217.98 $25,407,748.80
HEI – HEICO Corp. $30,588,000 $70.20 $23,983,408.80
JPM – JPMorgan Chase & Co. $30,066,000 $83.50 $18,009,280.00
FB – Facebook Inc. $29,390,000 $149.83 $21,454,157.70
ROK – Rockwell Automation Inc. $28,394,000 $126.89 $17,777,289.00
ROL – Rollins Inc. $27,169,000 $35.00 $28,677,250.00
LUV – Southwest Airlines $26,478,000 $31.94 $15,666,570.00
LBRDA – Liberty Broadband Corp. CL A $25,566,000 $87.38 $17,934,745.00
LSXMK – Liberty SiriusXM Series C $25,129,000 $25.48 $13,300,560.00
SEIC – SEI Investments $25,092,000 $38.56 $14,776,192.00
CVS – CVS Health Corp. $24,665,000 $54.70 $18,160,400.00
DAL – Delta Air Lines Inc. $24,386,000 $21.35 $8,902,950.00
PH – Parker-Hannifin $24,411,000 $102.43 $12,148,198.00
CMCSA – Comcast Corp. $23,429,000 $33.37 $17,385,770.00
LBRDK – Liberty Broadband Corp. CL C $21,643,000 $90.67 $15,605,485.71
CHH – Choice Hotels Int. Inc. $20,996,000 $57.67 $11,707,010.00
LSXMA – Liberty Sirius XM Series A $20,593,000 $25.33 $10,790,580.00
LNAGF – Linde AG $20,098,000 $151.30 $14,282,720.00
PEP – PepsiCo Inc. $19,899,000 $103.93 $15,132,208.00
SHW – Sherwin-Williams $18,090,000 $412.70 $12,793,700.00
ATVI – Activision Blizzard Inc. $16,685,000 $52.05 $14,615,640.00
CSCO – Cisco Systems $16,402,000 $35.60 $12,175,200.00
GOOGL – Alphabet Inc. $16,742,000 $1,068.21 $13,352,625.00
MCHP – Microchip Technology $16,651,000 $59.64 $9,482,760.00
MXIM – Maxim Integrated Products $15,501,000 $44.12 $11,118,240.00
EFX – Equifax Inc. $15,063,000 $105.65 $11,357,375.00
UNP – Union Pacific $15,434,000 $117.84 $10,060,000.80
HCSG – Healthcare Services Group $13,947,000 $21.58 $12,376,130.00
HXL – Hexcel Corp. $13,489,000 $32.01 $5,889,840.00
IFF – International Flav/Frag $13,676,000 $102.41 $10,855,460.00
BK – Bank of New York Mellon Corp. $12,784,000 $29.07 $7,383,780.00
EA – Electronic Arts $13,159,000 $86.94 $10,641,456.00
PAYX – Paychex Inc. $12,759,000 $51.97 $7,795,500.00
FWONK – Liberty Media Corp Formula One Series C $11,929,000 $23.00 $5,968,500.00
COST – Costco Co. $11,507,000 $290.42 $11,369,943.00
DLTR – Dollar Tree Inc. $11,578,000 $75.97 $9,351,907.00
AMT – American Tower Corp. $11,078,000 $195.39 $9,417,798.00
VRSK – Verisk Analytics Inc. $11,051,000 $124.25 $9,194,500.00
FWONA – Liberty Media Corp Formula One Series A $10,048,000 $20.85 $4,785,075.00
PM – Philip Morris Intl. $9,743,000 $61.09 $6,994,805.00
CDK – CDK Global Inc. $9,673,000 $30.98 $5,480,269.06
WFC – Wells Fargo $9,415,000 $26.50 $4,637,500.00
MCK – McKesson Corp. $8,728,000 $124.97 $7,885,607.00
AON – Aon Corp. $7,707,000 $149.55 $5,533,350.00
CABO – Cable ONE Inc. $7,740,000 $1,270.76 $6,607,952.00
CCK – Crown Holdings $8,124,000 $46.96 $5,259,520.00
TRU – TransUnion $7,448,000 $54.98 $4,783,260.00
ALB – Albemarle Corp. $5,332,000 $53.43 $3,900,390.00
LBTYA – Liberty Global Inc. $4,070,000 $17.63 $3,155,770.00
OI – O-I Glass Inc. $4,175,000 $5.67 $1,984,500.00
TRUP – Trupanion Inc. $4,120,000 $23.84 $2,622,400.00
DISCA – Discovery Communications Inc. $3,567,000 $18.76 $2,194,920.00
GHC – Graham Holdings Co. $3,323,000 $317.12 $1,649,024.00
PAG – Penske Automotive Group $3,615,000 $22.09 $1,590,480.00
Y – Alleghany Corp. $3,461,000 $467.71 $2,024,248.88
BLL – Ball Corp. $2,716,000 $54.89 $2,305,380.00
AN – AutoNation Inc. $2,120,000 $26.50 $1,155,665.00
KHC – Kraft Heinz Co. $2,185,000 $22.28 $1,515,040.00
WRB – W.R. Berkley Corp. $1,866,000 $47.58 $1,284,660.00
C – Citigroup Inc. $1,623,000 $38.06 $773,379.20
DHI – D.R. Horton $1,654,000 $31.38 $983,668.86
SHAK – Shake Shack Inc. $1,799,000 $34.78 $1,050,356.00
BKNG – Booking Holdings Inc. $411,000 $1,177.43 $235,486.00
BUD – Anheuser-Busch InBev $1,067,000 $40.30 $523,900.00
LEN.B – Lennar Corp. CL B $1,075,000 $25.28 $607,984.00
IAC – IAC/InterActive Corp. $286,000 $130.75 $150,362.50
ILMN – Illumina Inc. $332,000 $242.00 $242,000.00
LEN – Lennar Corp. $329,000 $34.08 $201,072.00
Grand Total $7,202,787,000 $4,952,512,945.77

Brief thoughts on Discovery Communications (DISCK/A)

We had blogged about Discovery communications before here. On March 20th, the stock closed at $16.87 / share with 711 fully diluted shares outstanding generating a market cap of ~$12B. The company carries debt of $15.4B. The company also generated operating cash flow of $3.4B with a net income of $2.069B in 2019. Capital expenditure was $0.3B and interest payments were $0.7B. Since Discovery always plans to carry a debt load of 3-3.5X, it might be wise to assume the interest payment stays for ever, the FCF adjusted for interest payments is $2.4B. The company is trading at 5 times adjusted FCF and 10 adjusted FCF to market cap.

There are two basic questions that we need to probe further.

a. Is there any possibility of running into liquidity issues or rolling over debt for the company?

b. Effect of Coronavirus and its implications for the company?

Debt position: Since Discovery has $15B of debt on its book, it might be worthwhile to see the amount that might come up for renewal in the near future. As seen below, $600M of 2.8% senior notes are coming for renewal in June. $600M in 2021 and close to $1.2B in 2022.

Screenshot 2020-03-21 at 12.36.04 PM

It is clear that the company can cover the interest principal payments very well with internal cash flow even if they are not able to tap the capital markets in 2020 and 2021. Liquidity and capital positions look solid from that point of view. Unless the cash flow falls completely off the cliff that would put the debt covenants in default, it looks like Discovery might be well placed.

Screenshot 2020-03-21 at 3.16.45 PM

Covid impact: On one hand, since the entertainment options for people have reduced in the last few weeks due to Covid, it is possible it might be a positive for the company. However, given the economic crunch that is sure to follow, one must consider whether the cord cutting will accelerate costing subscribers and a permanent FCF reduction to Discovery. This will be a function of the length of the slump and it is too early to call that.  I have no insight except that the markets have priced in a massive slump and China and Korea recovered in a 2-3 months.

Discovery also had rights to broadcast Olympics in some countries but the CFO came out at the end of Feb and said that the financial impact would be minimal in case of a Olympics cancellation. In addition, the company holds insurance against cancellation.

With $1.6B of cash, $2.5B of accessible credit facilities, strong FCF generation YTD, a manageable debt to extinguish over the next 12-24 months, the company seems to be unnecessarily priced to extinction. Unless the economy turns into a depression type scenario, the unique content of discovery communications, coupled with the strong financial cushion allows it to weather short short term shocks well. It sure looks like a case of Mr. Market voting the company down in the short term creating interesting possibilities for cash rich investors.

Disclosure: Own DISCK

How small businesses have fared in the US during the last week?

A very sobering presentation by data aggregator, Womply, that tracks customer spending trends, can be found here. It shows how small businesses have been affected by Covid in the U.S. by sector in the last few days. The impact on cash flows in the near term will be the pacing factor in the recovery that we will see in the economy when things improve.

So far, the spiral downwards is accelerating with some sectors seeing massive dives in demand. Transportation was down -86% year on year (on a weekly basis); arts and entertainment down -56%; lodging down -40% and restaurants down -20%. With the rapidly evolving situation in states, restaurants and lodging have probably not seen the worst yet. On the other hand, it looks like food and beverage shops have had a strong week thanks to hoarding happening across the board.

The liquidity measures taken by banks, governments and authorities that will enable the small businesses to stay afloat either through payment deferrals, moratoriums, stimulus etc. and reaches the small businesses will be key over the next few weeks. As one evaluates the potential options to invest, one cannot but consider the effect of liquidity, capital positions and the ability of the companies to stay afloat in these conditions in various scenarios.

Thoughts on Buybacks and Berkshire

There are capital allocators and there are good capital allocators.

At one end of the spectrum, you have airlines who are being eviscerated for spending close to all their  free cash flow on buybacks. The management, fully aware of the operating leverage of their fixed assets, not only levered the company financially but also did not build up any resiliency in their balance sheets for any external shocks and are now looking for federal help to stem the crisis. Ditto with banks, where the supposedly Fort Knox balance sheets were tested and fed liquidity tap has opened up again and buybacks suspended. A classic case of buyback when the prices are high and not so much when they could be a bargain to their TBV.

On the other hand end of the spectrum, we have companies like Berkshire. While their equities portfolio is getting hammered with the rest of the market, they are sitting on mountains of cash ($128B+) as of Dec 2019 and an environment where they can deploy the cash effectively. Berkshire has resisted doing massive buybacks just because it had cash and is now looking smarter and better positioned than other companies that deployed a ton of cash at market highs.

Now the rubber will hit the road for Berkshire. They are in an environment where they can deploy cash more easily and furthermore the shares are trading at a multiple of book value that Berkshire has purchased stock back in the past.

H/T to @investor_bad who posts Berkshire daily BV with respect to the portfolio changes.